CALCA and neoplasm: In particular, one study demonstrated longer survival in patients with a radiological disease control [31], and two studies [27,33] demonstrated longer survival in patients with a biochemical response, evaluated through calcitonin assessment, which, in MTC, can indicate tumour recurrence or progression [44] and indicate a treatment response with good sensitivity [45,46].